An experienced pediatric surgeon, Mark Holterman, MD, is the founder and CEO of the Miriam Group. He is also a retired professor of surgery and pediatrics with the University of Illinois (U of I) College of Medicine-Peoria. Dr. Mark Holterman counts stem cell therapy among his areas of professional interest.
Also known as regenerative medicine, stem cell therapy involves the use of stem cells to repair tissue that has suffered damage due to injury, disease, or general dysfunction. Present in the human body at all stages of development and age, stem cells are base level cells that can take on specialized characteristics and functions to become any number of differentiated and specialized cell types, including muscle cells, bone cells, blood cells, and brain cells.
Although it is still in its infancy, stem cell therapy has vast potential, from replacing healthy cells lost to chemotherapy to repairing damaged internal organs. Doctors have already been performing successful stem cell therapy for years in the form of bone marrow transplants.
Also known as regenerative medicine, stem cell therapy involves the use of stem cells to repair tissue that has suffered damage due to injury, disease, or general dysfunction. Present in the human body at all stages of development and age, stem cells are base level cells that can take on specialized characteristics and functions to become any number of differentiated and specialized cell types, including muscle cells, bone cells, blood cells, and brain cells.
Although it is still in its infancy, stem cell therapy has vast potential, from replacing healthy cells lost to chemotherapy to repairing damaged internal organs. Doctors have already been performing successful stem cell therapy for years in the form of bone marrow transplants.
